Skip to main content
. 2020 Nov 27;22(1):66–73. doi: 10.1016/S1470-2045(20)30619-7

Figure 2.

Figure 2

The number of systemic anticancer treatment registrations observed per month, overall (A) and for first-line non-curative therapy (B), second-line non-curative therapy (C), and third-line or later non-curative therapy (D)

The dashed horizontal line shows the mean number of registrations for the control period.